Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00438932 · ClinicalTrials.gov registry record · NA
Low Phosphate Diets in Patients With Early Stages of Chronic Kidney Disease
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT00438932: Completed NA study, sponsored by Massachusetts General Hospital.
NCT00438932 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00438932, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about how the kidneys control the blood levels of phosphorus in patients with early chronic kidney disease. The ultimate goal is to use this information to design improved treatment strategies for phosphorus-related problems for the millions of patients with chronic kidney disease.
Interventions
- DRUG Placebo
- DRUG Lanthanum Carbonate
- DIETARY_SUPPLEMENT Low Phosphorus Diet
- DIETARY_SUPPLEMENT Unrestricted Phosphorus Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2007-01 |
| Est. Completion | 2010-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00438932
The ClinicalTrials.gov registry entry for NCT00438932 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00438932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00438932 about?
NCT00438932 is a clinical study titled "Low Phosphate Diets in Patients With Early Stages of Chronic Kidney Disease". The purpose of this study is to learn more about how the kidneys control the blood levels of phosphorus in patients with early chronic kidney disease. The ultimate goal is to use this information to design improved treatment strategies for phosphorus-related problems for the millions of patients wit...
What is the current status of trial NCT00438932?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2007-01. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00438932?
The interventions under investigation include: Placebo (DRUG), Lanthanum Carbonate (DRUG), Low Phosphorus Diet (DIETARY_SUPPLEMENT), Unrestricted Phosphorus Diet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00438932?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.